Interestingly, we found a significant anti-correlation between the score and the response to a BET inhibitor in clinical development in hematological cancers (GSK525762) in HMCLs (R2 = 0.4081; P-value < 0.05) (Figure 4C). Here, DNER is linked to hematopoietic and lymphoid cell neoplasm.